Abstract:Abstract Lung cancer remains the deadliest form of cancer, claiming the lives of 1.8 million individuals worldwide in 2020. While treatment options have improved with the advent of immune checkpoint inhibitors (ICI), many patients do not respond to immunotherapy or develop resistance following initial response. A significant subset of non-small cell lung cancer (NSCLC) patients harbor somatic co-mutations in Kirsten rat sarcoma virus (KRAS) and Liver kinase 1 [LKB1, also known as serine/threonine kinase 11 (STK11)] genes, whose tumors are characterized by a predominance of neutrophils and an immune suppressive tumor microenvironment (TME) that are resistant to ICI. Our studies revealed that all-trans retinoic acid (ATRA), a metabolite derived from vitamin A, sensitized a murine model of NSCLC (Kras G12D P53−/−Lkb1−/−; KPL) to PD-1 blockade. The ATRA and anti-PD-1 combination therapy improved local and systemic T cell activation and generated systemic tumor-specific immunity. We further observed that ATRA augmented anti-PD-1 efficacy in additional murine NSCLC models with or without LKB1 loss. To understand ATRA-mediated anti-tumor effects, we performed single cell RNA sequencing (scRNA-seq) of KPL murine tumors with or without 6 daily ATRA treatments. scRNA-seq analysis indicated a reduction of neutrophils as well as an enrichment in T cell and natural killer (NK) cell populations in the TME. Furthermore, scRNA-seq analysis revealed elevated expression of interferon (IFN) downstream genes in multiple immune subpopulations in the TME. Preliminary ex vivo studies indicated that ATRA increases NOX2 levels, intracellular reactive oxygen species (ROS), and IFN signaling in the myeloid-derived suppressor cells (MDSC) of KPL tumors. Our findings suggest that ATRA may reshape the TME by activating IFN signaling in multiple cell subtypes to sensitize resistant tumors to ICI immunotherapy. Citation Format: William P. Crosson, Rui Li, Ramin Salehi-Rad, Raymond J. Lim, Jensen Abascal, Bitta P. Kahangi, Edgar Perez Reyes, Michael Oh, Camelia Dumitras, Nico Edgar, Ryan Chew, Rashel Jacobo, Zhe Jing, Kostyantyn Krysan, Linh M. Tran, Steven Dubinett, Bin Liu. ATRA treatment induces an interferon response to reprogram the immunosuppressive tumor microenvironment and overcomes resistance to immune checkpoint inhibition in murine models of LKB1 deficient non small cell lung cancer. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5157.

All-Trans Retinoic Acid (Atra) Promotes Tumor Resistence To Nk Cells By Downregulating Tumor B7-H6 Expression

All‐trans Retinoic Acid Induces Leukemia Resistance to NK Cell Cytotoxicity by Down‐regulating B7‐H6 Expression Via C‐myc Signaling

Identification of Retinoic Acid As an Inhibitor of Transcription Factor Nrf2 Through Activation of Retinoic Acid Receptor Alpha

Oridonin Upregulates All-Trans Retinoic Acid Receptor Alpha And Induces Differentiation Of Nb4 Cells Though Nf-Kb Pathway

Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8 T-cell immunity.

All-trans retinoic acid induces autophagic degradation of ubiquitin-like modifier activating enzyme 3 in acute promyelocytic leukemia cells.

Abstract 4032: ATRA induces an interferon response to reprogram the immunosuppressive tumor microenvironment and overcomes resistance to immune checkpoint inhibition in murine models of LKB1-deficient non-small cell lung cancer

All-trans Retinoic Acid is Capable of Inducing Folate Receptor Β Expression in KG-1 Cells

All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro

Ha117 Endows Hl60 Cells with A Stem-Like Signature by Inhibiting the Degradation of Dnmt1 Via Its Ability to Down-Regulate Expression of the Ggl Domain of Rgs6

All-trans retinoic acid protects hepatocellular carcinoma cells against serum-starvation-induced cell death by upregulating collagen 8A2

All-Trans-Retinoic Acid Modulates Icam-1 N-Glycan Composition By Influencing Gnt-Iii Levels And Inhibits Cell Adhesion And Trans-Endothelial Migration

Upregulation of Cd54 and Downregulation of Hla-Abc Contribute to the Novel Enhancement of the Susceptibility of Hl-60 Cells to Nk Cell-Mediated Cytolysis Induced by Atra Plus Vpa

All-Trans Retinoic Acid Promotes Tgf-Beta-Induced Tregs Via Histone Modification But Not Dna Demethylation On Foxp3 Gene Locus

Abstract 5157: ATRA treatment induces an interferon response to reprogram the immunosuppressive tumor microenvironment and overcomes resistance to immune checkpoint inhibition in murine models of LKB1 deficient non small cell lung cancer

All-trans Retinoic Acid Induces Thrombospondin-1 Expression in Acute Promyelocytic Leukemia Cells Though Down-Regulation of Its Transcription Repressor, C-Myc Oncoprotein

All-trans Retinoic Acid (ATRA) Inhibits Insufficient Radiofrequency Ablation (Irfa)-Induced Enrichment of Tumor-Initiating Cells in Hepatocellular Carcinoma.

ATRA promotes PD-L1 expression to control gastric cancer immune surveillance

Distinct Role and Functional Mode of TR3 and RARα in Mediating ATRA-induced Signalling Pathway in Breast and Gastric Cancer Cells

Function of Retinoid Acid Receptor Α and P21 in All-Trans-retinoic Acid-Induced Acute T-lymphoblastic Leukemia Apoptosis

All-trans retinoic acid enhances murine dendritic cell migration to draining lymph nodes via the balance of matrix metalloproteinases and their inhibitors.